Extricating human tumour immune alterations from tissue inflammation.
Ontology highlight
ABSTRACT: Immunotherapies have achieved remarkable successes in the treatment of cancer, but major challenges remain1,2. An inherent weakness of current treatment approaches is that therapeutically targeted pathways are not restricted to tumours, but are also found in other tissue microenvironments, complicating treatment3,4. Despite great efforts to define inflammatory processes in the tumour microenvironment, the understanding of tumour-unique immune alterations is limited by a knowledge gap regarding the immune cell populations in inflamed human tissues. Here, in an effort to identify such tumour-enriched immune alterations, we used complementary single-cell analysis approaches to interrogate the immune infiltrate in human head and neck squamous cell carcinomas and site-matc
SUBMITTER: Mair F
PROVIDER: S-EPMC9132772 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature
ACCESS DATA